HLA-I molecules bind short peptides and present them for recognition by CD8+ T cells. The length of HLA-I ligands typically ranges from 8 to 12 amino acids, but high variability is observed across different alleles. Here we used recent in-depth HLA peptidomics data to analyze the peptide length distribution of 85 different HLA-I alleles. Our results revealed clear clustering of HLA-I alleles with distinct peptide length distributions, which enabled us to study the structural basis of peptide length distributions and predict peptide length distributions from HLA-I sequences. We further took advantage of our collection of curated HLA peptidomics studies to investigate multiple specificity of HLA-I molecules and validated these observations with binding assays. Explicitly modeling peptide length distribution and multiple specificity improved predictions of naturally presented HLA-I ligands, as demonstrated in an independent benchmarking based on 10 newly generated HLA peptidomes (27,882 unique peptides) from meningioma samples.
Introduction
The binding of short intracellular peptides to Human Leukocyte Antigen Class I (HLA-I) molecules is a key step for immune recognition and prediction of naturally presented HLA-I ligands is currently the most important and most selective feature used to predict T cell epitopes. Peptide HLA-I interactions have been extensively studied either with binding assays or by Mass Spectrometry (MS). In recent years, improvements in sensitivity of MS instruments has led to the identification of hundreds of thousands naturally presented peptides, which include cancer testis antigens and neo-antigens (Bassani-Sternberg et al., 2015 . Computational tools developed by ourselves and others have shown that HLA-I restriction can be predicted in large HLA-I peptidomics datasets, even in the absence of a priori information about HLA-I binding specificity using motif deconvolution (Bassani-Sternberg and Gfeller, 2016; Bassani-Sternberg et al., 2017) or peptide clustering approaches (Alvarez et al., 2018; Andreatta et al., 2017) . The use of MS data combined with these novel algorithms has led to refinement of known HLA-I motifs, identification of novel motifs, characterization of N-or C-terminal extensions and improved HLA-I ligand predictions (Abelin et al., 2017; Bassani-Sternberg and Gfeller, 2016; Bassani-Sternberg et al., 2017; Di Marco et al., 2017; Guillaume et al., 2018; McMurtrey et al., 2016; Nielsen et al., 2017; Pymm et al., 2017; Remesh et al., 2017; Ritz et al., 2016) .
In addition, HLA peptidomics data provide information about the length distribution of naturally presented HLA-I ligands. Interestingly, in a recent study, clear discrepancies were observed between length distribution of eluted peptides and length distribution predicted based on binding affinity for five HLA-I alleles . This work indicated that the peptide length distribution observed in naturally presented HLA-I ligands is the result of both distinct affinity values of HLA-I alleles for peptides of different lengths as well as length biases in the pool of peptides available for loading onto HLA-I molecules in the Endoplasmic Reticulum (ER).
However, most studies investigating peptide length distributions have been restricted to a few alleles (Abelin et al., 2017; Andreatta et al., 2017; Di Marco et al., 2017; Jurtz et al., 2017; Trolle et al., 2016) . Moreover, most existing HLA-I predictors, with the exception of recent versions of NetMHCpan (Jurtz et al., 2017) and NetMHC (Andreatta and Nielsen, 2016) , do not include length distribution corrections based on MS data.
Another important feature characterizing peptides interacting with HLA-I molecules is the potential influence of a given amino acid at one position on the amino acid preferences at other positions. This type of co-operative effects, which often reflect multiple specificity patterns (Gfeller et al., 2011) , can be captured with neural networks, support vector machines or mixture models. Such models have been widely used to predict the binding of peptides to HLA-I molecules (Andreatta and Nielsen, 2016; Nielsen et al., 2003) or to peptide recognition domains (Gfeller, 2012; Gfeller et al., 2011; Kim et al., 2012) . However few examples of actual amino acid correlations and multiple specificity have been documented among HLA-I ligands (Bassani-Sternberg and Gfeller, 2016; Peters et al., 2003) . It remains therefore unclear how prevalent these correlations are in HLA-I alleles.
In this work, we set out to analyze the peptide length distribution and multiple specificity of more than 80 HLA-I molecules using high quality HLA peptidomics data generated by ourselves and others. To this end, we expanded our recent motif deconvolution algorithm MixMHCp (Bassani-Sternberg and Gfeller, 2016) to better handle peptides of different lengths. Clear clustering of HLA-I alleles based on their peptide length distribution similarity was observed, which enabled us to investigate the structural basis of peptide length distributions and predict peptide length distributions based on HLA-I sequences. We then used MixMHCp to investigate multiple specificity in HLA-I molecules and validated these observations with binding assays. Both peptide length distribution and multiple specificity were then incorporated into our HLA-I ligand predictor MixMHCpred (Bassani-Sternberg et al., 2017) , leading to improved prediction accuracy of naturally presented peptides in ten meningioma samples. Finally, this work expands significantly the allelic coverage of MixMHCpred (123 HLA-I alleles in total), making it suitable to run predictions of naturally presented HLA-I ligands for most patients of caucasian origin.
Results

Peptide length distributions in HLA-I ligands
To study the length distribution of naturally presented HLA-I ligands, we used our collection of curated HLA peptidomics datasets, including two novel meningioma samples and reaching a total of 227'510 unique peptides (Tables S1 and Methods) .
We further expanded our recent motif deconvolution algorithm MixMHCp (Bassani-Sternberg and Gfeller, 2016) to better handle peptides of different lengths (Eq. 1-3 and Methods). Focusing on alleles with enough MS data (>200 ligands), we could estimate peptide length distributions for a total of 85 alleles ( Figure S1 ). As previously reported (Abelin et al., 2017; Andreatta and Nielsen, 2016; Jurtz et al., 2017; Trolle et al., 2016) , we observed significant differences in peptide length distributions between different alleles. To have a global view of the diversity of peptide length distributions across HLA-I alleles, we used t-SNE to represent in 2D the different HLA-I alleles based on the similarity of their peptide length distributions (Methods and Figure 1A ). Applying a standard hierarchical clustering enabled us to propose three distinct clusters of HLA-I alleles ( Figure 1A and 1B). Cluster 1 is composed of HLA-I alleles that accommodate many longer ligands (e.g., HLA-A01:01 or HLA-03:01). Cluster 2 contains alleles that can bind 10-and 11-mers, in addition to canonical 9-mers, but much less longer peptides (e.g., HLA-A02:01).
Finally, cluster 3 contains alleles with peptide length distributions peaked on 9-mers (e.g., HLA-C06:02) or 8-and 9-mers (e.g., HLA-B51:01) and much fewer longer peptides.
Some patterns emerged from this analysis in terms of which HLA-I alleles fall into which cluster. First, we observed a strong clustering of HLA-C alleles (mainly in cluster 3), whereas HLA-A and HLA-B alleles were more mixed, with few HLA-A alleles in cluster 3. As expected, HLA-B alleles found in cluster 3 also displayed peptide length distributions peaked at 8-and 9-mers and include alleles with anchor residues at P5 (e.g., HLA-B08:01, HLA-B14:02, HLA-B37:01) (Bassani-Sternberg and Gfeller, 2016) . To test whether the peptide length distributions peaked at 9-mers for HLA-C alleles reflected differences in binding affinity, we tested different ligands of HLA-C06:02, including both 9-mers and 10-mers with one additional amino acid at P7 or P6 (Methods and Figure 1C ). In all three cases we observed decreased binding affinity of the 10-mer peptides compared to the 9-mers. These results suggest that the preference for 9-mers of HLA-C06:02 is also due to lower binding affinity for longer ligands, in addition to the expected higher frequency of 9-mer peptides available for loading in the ER .
To explore the structural basis of peptide length distributions, we surveyed existing X-ray structures of HLA-I alleles in complex with 9-mer peptides (Table S3 ).
Interestingly, for most alleles found in cluster 1, we observed that the smallest distance between residues in the beta sheet of the HLA-I molecule and residues at non-anchor positions (P3 to P8) in the peptide is significantly larger than for alleles found in cluster 2 and 3 ( Figure 1D ). In addition, the average normalized B-factor of Ca atoms of residues P3 to P8 is significantly higher for alleles found in cluster 1 compared to alleles in cluster 2 and 3 ( Figure 1E and Methods). The lower distance between the residues in the beta sheet and those in the peptide together with the lower B-factors of peptides in complex with alleles from cluster 2 and 3 suggest that 9-mer ligands of these alleles are more constrained and therefore less free to bulge out in the presence of additional amino acids.
To further support this hypothesis, we note that HLA-B57:01 and HLA-B58:01 differ by only two residues in the HLA-I binding site (47 and 97) and have very similar binding motifs ( Figure 1F ). Position 97 is located close to non-anchor residues of the peptide (P3 to P8), while position 45 is buried in the B pocket ( Figure 1F ). In HLA-B57:01 valine is found at position 97 and does not interact directly with residues P3-P8 in the peptide (PDB: 2RFX , minimal distance equal to 5.4Å), while in HLA-B58:01 arginine is found at position 97 and makes direct interactions with the peptide (PDB: 5IND , minimal distance equal to 3.5Å) ( Figure 1F ). Consistent with the mechanism proposed above, HLA-B57:01 has a broader peptide length distribution than HLA-B58:01 ( Figure 1A ).
Predicting peptide length distributions
The clustering observed in Figure 1A suggests that it may be possible to predict peptide length distribution for a new HLA-I allele based on its sequence only, by predicting to which cluster it belongs and then mapping the average peptide length distribution of the cluster to this new allele. To this end, we trained a multinomial logistic regression, using as features all the HLA-I residues found in the binding site and as output the 3 clusters identified in Figure 1A (Methods). Five-fold crossvalidation was carried out, including both the clustering and the training of the multinomial logistic regression. The average correlation between observed and predicted peptide length distributions was 0.973. As a comparison, a random assignment of HLA-I alleles to the clusters during the cross-validation would result in an average correlation of 0.935. This clearly indicates that our approach has predictive power for peptide length distributions based on HLA-I sequences, beyond what is conserved across all HLA-I alleles (e.g., the higher frequency of 9-mers).
Amino acid frequencies at non-anchor positions
We next took advantage of our large collection of unbiased HLA-I ligands of different lengths to investigate the changes in amino acid preferences at non-anchor positions (P5 to PW-2) for alleles displaying at least 20 ligands for all peptide lengths L=8,…14
(13 alleles in total, see Methods). Importantly, these positions were not considered when assigning peptides of length 8 and 10-14 to their respective alleles with MixMHCp and therefore the analysis is not biased by the 9-mer motifs. Figure 2 shows the changes in amino acid frequencies with respect to peptide lengths. The first pattern that emerges from this analysis is the very clear increase in frequency of glycine in longer peptides. Glycine is known to destabilize secondary structures and induce protein disorder (Linding et al., 2003) . We anticipate that the higher frequency of glycine in longer HLA-I ligands enables them to adopt bulging conformations more easily. We also observed increased frequency of negatively charged residues (aspartate and glutamate), serine and to a lower extent alanine. Glycine, serine and alanine have small sidechains, which confirms at a larger scale the observation made for HLA-C04:01 ligands (Schittenhelm et al., 2014) . Disfavored amino acids in longer peptides include leucine, tryptophan, arginine, valine, phenylalanine, histidine and isoleucine. Many of them tend to induce structured conformations of polypeptides, further indicating that, on average, longer HLA-I ligands tend to be less structured at non-anchor positions. As noted in previous studies (Abelin et al., 2017; Bassani-Sternberg et al., 2017) , we also observed a very low frequency of cysteine at all peptide lengths, which is likely due to the fact that cysteine modifications are not included in standard MS spectral searches.
Multiple specificity in HLA-I ligands
To study cases of multiple specificity, we applied the new version of the MixMHCp algorithm to each dataset of HLA-I ligands, treating separately peptides of different lengths (Methods). All motifs were manually reviewed and our results revealed several instances of multiple specificity (Figure 3) . These include the previously reported multiple specificity of HLA-B07:02 (Bassani-Sternberg and Gfeller, 2016) , as well as cases of C-terminal extensions in 10-mers for HLA-A03:01 and HLA-A68:01 (orange boxes in Figure 3 ) (Guillaume et al., 2018) . For HLA-B07:02, the multiple specificity predicts mutual exclusivity of positively charged residues at P3 and P6. In our previous work, we had proposed a structural explanation for this observation, involving the presence of aspartate in the HLA binding site at position 114 which can interact with one, but not two positively charged residues in the peptide (Bassani-Sternberg and Gfeller, 2016) . A similar multiple specificity is observed for HLA-C16:01 ( Figure 3 , red boxes), and this allele has also aspartate at position 114. For HLA-B35:08, existing structures indicate that R156 can interact with residues at P3 (PDB: 2AXF (Tynan et al., 2005) ) or P5 (PDB: 2FZ3 (Miles et al., 2006) ) ( Figure 4A ), which is consistent with the mutual exclusivity of negatively charged residues observed at these 2 positions in MS data (Figure 3 , cyan boxes).
For two alleles (HLA-A03:01 and HLA-B51:01), we set out to validate these predictions. For HLA-A03:01, the multiple specificity model predicted that the binding of peptides with R/K at P9 should not be much influenced by the amino acid at P7, while peptides with Y/H at P9 should show additional specificity for leucine at P7. These predictions could be validated by observing that L7A mutation of peptides with K at P9 did not affect the binding, while L7A mutation decreased the binding of peptides with Y or H at P9 ( Figure 4B ). For HLA-B51:01, peptides with sequences predicted to follow the two binding specificities (i.e., L1P2 and D1A2), as well as the other possibilities (i.e., D1P2 and L1A2) were tested. The latter are predicted to display weaker binding, although the single 9-mer logo of HLA-B51:01 would naively predict D1P2 to show the highest stability ( Figure 3 ). For both 9-mers and 8-mers, we could confirm the predictions of the multiple specificity analysis by observing that peptides with either L1P2 or D1A2 displayed higher stability than ligands with D1P2 or L1A2 ( Figure 4C ). Comparison of HLA-B51:01 crystal structures in complex with two different ligands (L1P2 in blue and T1A2 in orange in Figure 4D ) (Maenaka et al., 2000) indicates that the polar group of T1 interacts with R62, which is consistent with the specificity for negatively charged or polar residues seen in MS data at P1.
Reversely, in the presence of L1, the sidechain of R62 points towards the solvent. In addition, superposition of the two structures suggest that proline at P2 may not be compatible with the position of the threonine sidechain at P1. This suggests a possible explanation for the multiple specificity of HLA-B51:01. If alanine is found at P2, then negatively charged or polar amino acids are preferred at P1 and can make interactions with R62. Reversely, if proline is found at P2, amino acids at P1 cannot make direct interactions with R62, which is then pointing towards the solvent, and hydrophobic sidechains are preferred at P1. It is also interesting to note that one of the first neoantigens identified by MS (DANSFLQSV) in melanoma samples (Kalaora et al., 2016) matches very precisely the second motif of HLA-B51:01 identified in this work.
Incorporating peptide length distribution and multiple specificity in HLA-I ligand predictors
To incorporate peptide length distribution and multiple specificity in HLA-I ligand predictors, and explore whether this would lead to improved predictions of naturally presented HLA-I ligands, we developed a new version of MixMHCpred (v2.0).
Peptide length distribution information was incorporated by adding a penalty so that the length distribution of the top 1% of peptides predicted from a pool of 700'000 random peptides (100'000 of each length L=8,...,14) follows by construction the distribution observed in MS data (Eq. 5 and Methods). For all alleles displaying multiple specificity, their binding specificity was modeled with multiple Position Weight Matrices (PWMs) (Eq. 6 and Methods).
To validate this new version of our predictor in an independent dataset, we measured the HLA peptidome of 10 meningioma samples (Methods), resulting in 27,882 unique peptides of length 8 to 14. We then attempted to predict these peptides by adding 4 times more negative data consisting of 8-to 14-mer peptides randomly sampled from the human proteome (Methods). Figure 5 shows the results in terms of precision in the top 20% of the predictions (which is equal to recall since we have a 4-fold excess of negative data) and Area Under the receiver operating Curve (AUC) values. In all cases, we saw clear improvement by adding correction for peptide length distributions (compare 1 st and 3 rd bars, as well as 2 nd and 4 th bars in Figure 5 ). Moreover, in all but one sample containing alleles that were shown to display multiple specificity (stars in Figure 5 ), we observed that including multiple specificity led to equal or better results (compare 1 st and 2 nd bars, as well as 3 rd and 4 th bars in Figure 5 ). When comparing with the other predictor of naturally presented HLA-I ligands that includes MS data in its training set (i.e., NetMHCpan4.0 (Jurtz et al., 2017) ), we could observe better performance in precision for all samples and in AUC values for all but one sample (compare 4 th and 5 th bars in Figure 5 ).
Discussion
In-depth and unbiased sampling of naturally presented HLA-I ligands is a powerful approach to unravel new properties of HLA-I molecules (Abelin et al., 2017; Alvarez et al., 2018; Bassani-Sternberg and Gfeller, 2016; Bassani-Sternberg et al., 2017; Di Marco et al., 2017; Guillaume et al., 2018; Schittenhelm et al., 2014; Trolle et al., 2016) . In this work, we capitalized on these data to explore peptide length distribution and multiple specificity of HLA-I molecules at a much larger scale than previous studies. Our work revealed clear clustering of HLA-I alleles based on their peptide length distribution, which could guide investigation of the structural properties underlying the preference for peptides of different lengths. One clear pattern that emerged from our analysis is the restriction of HLA-C alleles to mainly 8-and 9-mers (Di Marco et al., 2017) . The restriction of HLA-C alleles to short peptides may also have functional implications. In addition to T Cell Receptors (TCRs) that can somatically rearrange their sequences to bind a wide range of HLA-I restricted targets, HLA-C alleles are the main targets of Natural Killer (NK) receptors which are germline encoded. Numerous crystal structures indicate the NK receptors bind to HLA-I alleles on top of the F pocket (Boyington et al., 2000; Pymm et al., 2017) .
Longer peptides bulging out or extending at the C-terminus (Guillaume et al., 2018; McMurtrey et al., 2016; Remesh et al., 2017) , may therefore interfere with the binding of NK receptors (Pymm et al., 2017) . This could explain why HLA-C alleles have evolved to preferentially bind to 8-and 9-mers. Our work further enabled us to demonstrate, for the first time to our knowledge, that peptide length distributions can be predicted directly from HLA-I sequences, as shown in our cross-validation study.
The multiple specificity observed in this work suggests that, for some alleles, correlations between amino acid positions play an important role in binding to the HLA-I molecules (e.g., L1P2 and D1A2 being much more frequent to D1P2 or L1A2 in B51:01). These types of correlations, which we implicitly modelled with multiple PWMs, can also be captured with more complex machine learning frameworks, such as neural networks. It is worth noting that, from a mathematical point of view, multiple PWMs share many similarities with hidden nodes in neural networks, with the main difference being that the inputs of nodes in standard neural networks are combined with a logistic regression, whereas we use linear combinations in Eq. 6. As already observed for peptide recognition domains (Gfeller, 2012; Gfeller et al., 2011; Kim et al., 2012) , an important advantage of the multiple PWMs framework is the straightforward visualization, which is useful to guide structural interpretation and experimental validation of the predictions. Nevertheless, the fact that only 10% of HLA-I alleles displayed clear multiple specificity and the modest improvement in prediction obtained by incorporating multiple specificity ( Figure 5 ) suggest that the assumption of positional independence is still a good approximation for modeling the specificity of most HLA-I alleles (Peters et al., 2003) .
Altogether, our work provides the first large-scale analysis of peptide length distributions and multiple specificity in naturally presented HLA-I ligands. Including these two features into our predictor led to improved predictions of peptides presented on the surface of meningioma samples, and may therefore contribute to accelerating (neo-)antigen discovery in cancer immunotherapy.
Methods
Expanding motif deconvolution to peptides of different lengths
Binding motif deconvolution in HLA-I peptidomes with the previous version of the mixture model (MixMHCp1.0) performs well in many samples for 9-and 10-mers (Bassani-Sternberg and Gfeller, 2016; Bassani-Sternberg et al., 2017) . However, it often fails for 8-mers and for longer (>10-mers) peptides, since much less data is available for them in MS samples. To overcome this limitation, we introduce here a new approach to better handle peptides of different lengths. Motif deconvolution is first carried out on 9-mers as previously done in MixMHCp1.0 (Bassani-Sternberg and Gfeller, 2016; Bassani-Sternberg et al., 2017) . For peptides of other lengths, the motifs used in the mixture model are fixed, based on the first three and last two positions of the 9-mer motifs, and only the weights of the different motifs are learned from the data. The underlying justification for this approach is that HLA-I motifs, and especially positions close to the anchor residues, differ only slightly between 9-mers and other peptide lengths. However, the proportion of peptides from each allele in HLA-I peptidomics samples is likely to differ substantially for different peptide lengths, because of the different length distributions of HLA-I alleles. In addition, we integrated a flat motif (fixed values at all positions) in the mixture model to which peptides that do not match any motif inferred from the data can be assigned. This is useful to remove potential contaminants in MS data (Alvarez et al., 2018) .
In mathematical terms, the new log-likelihood function for the peptides of length equal to core length (hereafter core length equals to 9) is defined as: (Eq. 1)
where M k represents the k th motif, , 2 represents the weight of this motif in the 9-mer peptides, , the number of 9-mer ligands, @ = ( 9 @ , … , , @ ) the n th ligand of length 9 and prior ( ) the prior on the PWM entries as defined in (Gfeller et al., 2011; Kim et al., 2012) . The Pi (i=1,…,20) values are taken as the amino acid frequencies in the human proteome and represent a flat motif to which peptides that do not match any of the other motifs can be assigned, similar to the trash cluster in GibbsCluster (Andreatta et al., 2013 . This log-likelihood can be efficiently maximized used Expectation-Maximization (Gfeller et al., 2011; Kim et al., 2012) . penalties assigned to extensions and represent the fact that, on average, cases where a motif can be found both at the terminus and within the peptide sequence correspond to bulges (Guillaume et al., 2018) . The optimal number of motifs and the assignment of the different motifs to different alleles in each sample was determined as described in our previous work based on 9-mers (Bassani-Sternberg and Gfeller, 2016; Bassani-Sternberg et al., 2017) and all motif annotations were manually reviewed.
Collection of publicly available HLA peptidomics data
Publicly available HLA peptidomics datasets from mono-allelic studies (Abelin et al., 2017; Di Marco et al., 2017; Guasp et al., 2016; Hilton et al., 2017) and pooled studies (Bassani-Sternberg et al., 2015 Gloger et al., 2016; Mommen et al., 2014; Pearson et al., 2016; Ritz et al., 2016 Ritz et al., , 2017 were considered in this work (Table S1 ). Almost all these samples were measured with 1% FDR and none of them was filtered by existing predictors. For the samples from (Pearson et al., 2016) , raw MS data were reprocessed and the list of peptides is available in (Bassani-Sternberg et al., 2017) . For the samples from (Di Marco et al., 2017) , the list of peptides before filtering was kindly provided to us by the authors of this study. Finally IEDB (Vita et al., 2015) data (as of March 2018) were also collected, treating separately those annotated as "ligand presentation" (MS data) and those not (non-MS data).
Motif deconvolution in HLA peptidomes
All When incorporating peptide length distributions into our predictor (i.e., to compute the shifts, see below), a smoothing procedure was applied based on the average
for each cluster c (c=1,2,3):
with b=100, g=10 and c=1, 2 or 3 depending on the cluster of allele h and S c the set of alleles in cluster c. This will be especially useful for alleles without MS data ( ] ( ) = 0), see below.
Prediction of peptide length distributions
To predict peptide length distribution directly from HLA-I sequences, we aligned the amino acid sequences of all alleles with at least 200 ligands found by MS. We then trained a multinomial logistic regression to predict the clusters observed in Figure 1A (cv.glmnet, as implemented in R), using as input the amino acids at each position in the HLA-I binding site (i.e., positions 5, 7, 9, 33, 45, 59, 63, 66, 67, 69, 70, 73, 76, 77, 80, 81, 84, 97, 99, 114, 116, 123, 142, 143, 146, 147, 152, 156, 159, 163, 167 and 171, following residue numbering in X-ray structures), based on standard 20dimensional encoding of amino acids. Cross-validation was carried out by randomly splitting into five groups the alleles shown in Figure 1A and iteratively training the model (including both the clustering and the logistic regression) on four groups and testing the predictions on the 5 th group. In the testing set, the predicted length distribution of a given allele was taken as the average length distribution over the alleles of the cluster to which this allele was assigned and the correlation between the predicted length distribution and the actual one was computed. Average correlation reported in the manuscript corresponds to the average over all alleles and over ten different random choices of the groups used in the cross-validation (distinct random seeds). For comparison, correlations obtained by random cluster assignment of alleles in the testing sets were computed. This is important since peptide length distributions of all HLA-I molecules share common features, so we always expect some level of correlation between predicted and actual peptide length distributions, even with a random predictor.
Finally, for HLA-I alleles without MS data, the clusters were predicted with the logistic regression trained on the full dataset of alleles with MS data (85 alleles in total) and the predicted peptide length distributions for these alleles correspond to the average length distribution of the alleles belonging to the cluster where it was assigned, plus a flat pseudo-count given by g (Eq. 4).
Amino acid frequencies at non-anchor positions
Alleles with at least 20 ligands for all lengths L=8,…14 were selected (i.e., A01:01, 
Building Position Weight Matrices
The training set of our HLA-I ligand predictor MixMHCpred was built as previously described (Bassani-Sternberg et al., 2017) , adding two new meningioma samples measured in this work (3911-ME_I and 4021_I, representing 4,719 unique peptides of length L=8,…,14) and several recent HLA peptidomics studies (Di Marco et al., 2017; Guasp et al., 2016; Hilton et al., 2017; Ritz et al., 2017) . For alleles with less than 200 peptides, MS data from IEDB (Vita et al., 2015) were further included. For alleles that still had less than 20 peptides, in vitro binding data from IEDB were used (treating as positives all entries not annotated as "Negatives"). This led to a total of 123 alleles for which we could obtain ligands and build PWMs for length L=8 to . In a few cases, no ligand was available for L=8, and we used the 9-mer PWMs, removing the middle position with the lowest binding specificity. In a few other cases, ligands were not available for longer peptides (L=10,…,14) . In these cases, a non-specific position was added to (],DR9) right after position L-4. Of note, these cases contribute only marginally to the predictions when incorporating peptide length distribution in the predictor, since by construction the corresponding lengths are given a very low weight (see below).
Explicitly modeling length distribution in HLA-I ligand predictors
The scores given by standard PWMs result in peptide length distributions that do not follow those observed in MS data. To explicitly model the peptide length distributions of naturally presented ligands, we added a correction factor to the scoring of peptides of different lengths:
The correction factors (],D) were computed as the score corresponding to 100 × ] ( ) percentile rank for 100'000 L-mers (randomly selected from the human proteome) without the correction factor. In this way, the top 1% peptides predicted from a set of 700'000 8-to 14-mers (100'000 of each length) follows by construction the distribution ] ( ) derived from MS data and positive scores indicate peptides in the top 1% of the predictions while negative scores indicate peptides in the low 99% of the predictions for a single allele.
Multiple specificity analysis
All peptides annotated to the same allele were re-analyzed with our mixture model to identify multiple motifs. Peptides of different lengths were treated separately, always setting the core length equal to the peptide length in MixMHCp. Treating separately peptides of different lengths is important for multiple specificity analysis since peptides of different length may not display the same multiple specificity patterns (see example of C-terminal extensions in Figure 3 ). All cases were then manually reviewed to determine whether the multiple motifs differed significantly from the single motif (Figure 3 ).
To investigate whether multiple specificity could improve HLA-I ligand predictions, we modeled these cases with multiple PWMs using the framework introduced previously by ourselves for peptide recognition domains (Gfeller et al., 2011; Kim et al., 2012) and recently applied to model C-terminal extensions in 10-mer HLA-I ligands (Guillaume et al., 2018) . Peptides were assigned to each motif identified by the mixture model based on the highest responsibility values and multiple PWMs ( (],D,2) ) were built as described above performed for all samples (Table S1 ). Informed consent of the participants was obtained following requirements of the institutional review board (Ethics Commission, CHUV). Protocol F-25/99 has been approved by the local Ethics committee and the biobank of the Lab of Brain Tumor Biology and Genetics.
We extracted HLA-I peptides from the meningioma samples as previously described In case of assigned precursor ion charge states of four and above, no fragmentation was performed.
We employed the MaxQuant computational proteomics platform version 1.5.5.1 (Tyanova et al., 2016) (Table S2) .
Two of these samples (3911-ME_I and 4021_I) were included in the peptide length distribution and multiple specificity analysis as well as the training of the new version of the HLA-I ligand predictor (MixMHCpred2.0), since they contained alleles (HLA-B49:01 and HLA-C15:05) whose motifs were not detected in our collection of publicly available HLA peptidomics studies, and therefore enabled us to expand the allelic coverage of MixMHCpred. The other ten datasets were kept for benchmarking of the new version of MixMHCpred ( Figure 5 ) and were not included in any training procedures presented in this work.
Benchmarking MixMHCpred2.0
To benchmark our new algorithm (MixMHCpred2.0), we used the ten HLA peptidomes from meningioma samples that were measured in this study. Negative data were chosen by randomly selecting peptides from the human proteome so as to have 4 times more negative than positive. Peptides of lengths 8 to 14 were uniformly selected in the negative data. When attempting to predict peptides naturally presented in meningioma samples with many (i.e. up to six) different HLA-I alleles, we used for each peptide the highest score of MixMHCpred2.0 across all alleles. Precision in the top 20% of the predicted peptides (which is also equal to recall in the case of 4-fold excess of negative data) and Area Under the ROC curve were computed for each sample (4 th bars in Figure 5 ). MixMHCpred2.0 scores were also computed in the absence of peptide length distribution corrections and multiple specificity (1 st bars in Figure 5 ), absence of peptide length distribution corrections (2 nd bars in Figure 5 ) or absence of multiple specificity (3 rd bar in Figure 5 ). When benchmarking with NetMHCpan4.0 (Jurtz et al., 2017) , we used the percentile rank of the elution scores and chose the lowest percentile rank across all alleles for each peptide (5 th bar in Figure 5 ).
X-ray structures of HLA-I alleles
X-ray structures of HLA-I alleles shown in Figure 1A were retrieved from the PDB.
A representative structure for each allele was selected based on (i) the fact that the ligand is a 9-mer (ii) the absence of other receptors binding to the peptide-HLA-b2m
complex (e.g., TCR or KIR, the only exception is HLA-C03:04 for which a crystal structure was only available in complex with KIR2DL2) and (iii) the lowest R value.
This led to a total of 30 alleles with X-ray structures in complex with 9-mers (Table   S3 ).
Euclidean distances between the peptides and the beta sheet of the HLA-I molecules were computed as the smallest distance of any heavy atom of the peptide (P3 -PW-1)
with any heavy atom of residues in the beta sheet (positions 5, 6, 7, 8, 9, 10, 11, 12, 23, 24, 25, 26, 27, 28, 95, 96, 97, 98, 99, 100, 101, 113, 114, 115, 116, 117 and 118) .
Most of the time, the residue closest to the peptide in the beta sheet is residue 97, which is located in the center of the binding site and points towards the non-anchor residues of the ligand. In each structure, B factors for all Ca atoms of the peptides (P3 -PW-1) were averaged and this value was normalized by the average of B factors of all Ca atoms of the HLA-I molecule to enable meaningful comparison between different structures.
In vitro refolding assays
All peptides used in refolding assays with HLA-A03:01, HLA-B07:02, HLA-B15:01
and HLA-C06:02 were synthesized with free N and C-termini (1mg of each peptide, > 80% purity). Peptides were incubated separately with denaturated HLA-I alleles refolded by dilution in the presence of biotinylated beta-2 microglobulin proteins at temperature T=4°C for 48 hours. The solution was then incubated at 37°C. Samples were retrieved at time t=0h, 8h, 24h, 48h and t=72h. Stable complexes indicating interactions between HLA-I molecules and the peptides were detected by ELISA.
Two independent replicates were performed for each measurement in Figure 4B and 4C and four independent replicates for each measurement in Figure 1C . Positive controls were used to renormalize the values between the different replicates. Figure S1 : Peptide length distributions estimated from HLA peptidomics data for the 85 HLA-I alleles with >200 naturally presented ligands studied in this work (see also Figure 1 ). Table S1: List of HLA peptidomics datasets used in this work, together with the HLA typing information. 
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